NCI

Active Purchase Order Awarded Last action

Contract number
75N98026P00913
Awardee
Awarding agency
Obligated
$56,857

Award facts

Contract value 100% obligated
$56,856.60 Current and potential, with all options
Completion date 29% complete
Current and potential, with all options
Funding agency
National Cancer Institute National Institutes of Health, Department of Health and Human Services
Set-aside
Total Small Business
Competition
Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
San Diego, CA 92121, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00001 -$578
Original award $57,435

About this award

The National Cancer Institute awarded a purchase order to Invivoscribe, Inc. for $56,856.60 on July 2, 2026, under a Total Small Business set-aside. The order procures IGH+IGK clonality mega-ABI diagnostic materials and is firm fixed price. Place of performance is San Diego, California. Ultimate completion is July 1, 2027.

Quick answers

Who was awarded contract 75N98026P00913?

75N98026P00913 was awarded to Invivoscribe, Inc. by Office of Logisitics and Acquisition Operations (National Institutes of Health) on July 2, 2026.

How much is contract 75N98026P00913 worth?

The government has obligated $56,857 on 75N98026P00913.

Which agency awarded contract 75N98026P00913?

Office of Logisitics and Acquisition Operations (National Institutes of Health) awarded 75N98026P00913, with funding from National Cancer Institute (National Institutes of Health).

Was contract 75N98026P00913 competed?

The extent of competition for 75N98026P00913 was competed under sap. The government received 1 offer. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award